Monotherapy Epilepsy: TOPAMAX is indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older.
Adjunctive Therapy Epilepsy: TOPAMAX is indicated as adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older.
Migraine: TOPAMAX is indicated for the preventive treatment of migraine in adult patients.